Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIIOngoingMar 13, 2024Clindamycin PhosphateDefective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.Contract Pharmaceuticals Limited Canada · D-0364-2024Class IIOngoingMar 6, 2024Lidocaine HCL 1%Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.Denver Solutions, LLC DBA Leiters Health · D-0363-2024Class IIOngoingMar 6, 2024Moxifloxacin 5mg/mlPresence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.Denver Solutions, LLC DBA Leiters Health · D-0362-2024Class IIOngoingMar 6, 2024Moxifloxacin PFPresence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.Denver Solutions, LLC DBA Leiters Health · D-0361-2024Class IITerminatedMar 6, 2024PROBLEND Hand SanitizerCGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.Seatex LLC · D-0360-2024Class IITerminatedMar 6, 20247 Eleven Hand Sanitizer GelCGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.Seatex LLC · D-0359-2024Class IITerminatedMar 6, 20247 Eleven FOR GAS ISLAND USE ONLYCGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.Seatex LLC · D-0358-2024Class IITerminatedMar 6, 2024PROBLEND E3 Foaming Hand SanitizerCGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.Seatex LLC · D-0357-2024Class IITerminatedMar 6, 2024PROBLEND Antibacterial Foaming Silk All-In-One Foaming Hand Sanitizer & CleanserCGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.Seatex LLC · D-0356-2024Class IICompletedMar 6, 2024Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1Subpotent Drug: Out of specification for assayBausch Health Companies, Inc. · D-0355-2024Class IIOngoingMar 6, 2024Lubricant PM OintmentLack of Assurance of SterilityBrassica Pharma Pvt Ltd · D-0354-2024Class IIOngoingMar 6, 2024CVS Health Lubricant Eye OintmentLack of Assurance of SterilityBrassica Pharma Pvt Ltd · D-0353-2024Class IIOngoingMar 6, 2024Equate Stye Lubricant Eye OintmentLack of Assurance of SterilityBrassica Pharma Pvt Ltd · D-0352-2024Class IIOngoingMar 6, 2024Equate Lubricant Eye OintmentLack of Assurance of SterilityBrassica Pharma Pvt Ltd · D-0351-2024Class IIOngoingMar 6, 2024Mesalamine Extended-Release CapsulesFailed Dissolution Specifications: Out of specification for dissolution.Sun Pharmaceutical Industries Inc · D-0350-2024Class IIOngoingMar 6, 2024Fluticasone Propionate Nasal Spray USPCGMP Deviations:Suspected potential presence of Burkholderia cepacia complexGolden State Medical Supply Inc. · D-0349-2024Class IIOngoingFeb 28, 2024Clobazam Tablets 10mgCGMP Deviations: Out of specification for residual solvents.Micro Labs Limited · D-0348-2024Class IITerminatedFeb 28, 2024CABTREOCGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining...Mckesson Corporation · D-0347-2024Class ICompletedFeb 28, 2024TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray LiquidChemical Contamination; presence of benzene.Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company · D-0346-2024Class IOngoingFeb 28, 2024Arize Herbal Dietary SupplementMarketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the...Today The World · D-0345-2024Class IOngoingFeb 28, 2024SCHWINNNG Herbal Dietary SupplementMarketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the...Today The World · D-0344-2024Class IOngoingFeb 28, 2024Sustain Herbal Dietary SupplementMarketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products for the...Today The World · D-0343-2024Class IICompletedFeb 28, 2024AdrenalinLabeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.Henry Schein Inc. and Glove Club HSI Gloves Inc. · D-0342-2024Class IIOngoingFeb 28, 2024TerlivazcGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.Mallinckrodt Hospital Products Inc. · D-0341-2024Class IIOngoingFeb 28, 2024Acthar GelcGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.Mallinckrodt Hospital Products Inc. · D-0340-2024Class IIOngoingFeb 28, 2024Fosfomycin Tromethamine Granules for Oral SolutionFailed Impurities/Degradation Specification: Out of specification for organic impuritiesAscend Laboratories, LLC · D-0339-2024Class IITerminatedFeb 28, 2024Pure Care Foaming Mint Hand Sanitizer 62%CGMP DeviationsAlpha Aromatics · D-0338-2024Class IITerminatedFeb 28, 2024Voriconazole for Oral SuspensionLabeling: Incorrect or Missing Package InsertLupin Pharmaceuticals Inc. · D-0337-2024Class IIOngoingFeb 28, 2024Norepinephrine Bitartrate in 5% Dextrose InjectionIncorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label...Baxter Healthcare Corporation · D-0336-2024Class IOngoingFeb 28, 2024Neptune's FixMarketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.Neptune Resources, LLC · D-0335-2024Class IOngoingFeb 28, 2024Neptune's FixMarketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.Neptune Resources, LLC · D-0334-2024Class IOngoingFeb 28, 2024Neptune's FixMarketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.Neptune Resources, LLC · D-0333-2024Class IITerminatedFeb 28, 2024Equate Cherry Cough DropsCGMP Deviations: Potential Glass and Silicone particulates in productBestco LLC · D-0332-2024Class IITerminatedFeb 28, 2024Family Wellness Cherry Cough Drops Menthol cough suppressant/Oral AnestheticCGMP Deviations: Potential Glass and Silicone particulates in productBestco LLC · D-0331-2024Class IITerminatedFeb 28, 2024Kroger Cherry Cough DropsCGMP Deviations: Potential Glass and Silicone particulates in productBestco LLC · D-0330-2024Class IITerminatedFeb 28, 2024Meijer Cherry Cough DropsCGMP Deviations: Potential Glass and Silicone particulates in productBestco LLC · D-0329-2024Class IITerminatedFeb 28, 2024CVS Health Cherry Cough DropsCGMP Deviations: Potential Glass and Silicone particulates in productBestco LLC · D-0328-2024Class IITerminatedFeb 28, 2024Oseltamivir Phosphate for Oral Suspension 6mg/mlFailed Impurities/Degradation Specifications: Out-of-specification test results.Amneal Pharmaceuticals of New York, LLC · D-0327-2024Class IIOngoingFeb 28, 2024Fluticasone Propionate Nasal Spray USP 50mcgCGMP Deviations: potential presence of Burkholderia cepacia complexApotex Corp. · D-0326-2024Class IIOngoingFeb 21, 2024Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for InjectionSub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.IntegraDose Compounding Services LLC · D-0325-2024